Changes in key measures from the start of the study to the last mid-luteal phase visit were assessed. Absolute changes in body mass index, waist circumference and fasting glucose were all smaller in the metformin group compared to the placebo group, indicating metformin was more effective at preventing increases in these measures over time compared to placebo.
Changes in key measures from the start of the study to the last mid-luteal phase visit were assessed. Absolute changes in body mass index, waist circumference and fasting glucose were all smaller in the metformin group compared to the placebo group, indicating metformin was more effective at preventing increases in these measures over time compared to placebo.
Changes in key measures from the start of the study to the last mid-luteal phase visit were assessed. Absolute changes in body mass index, waist circumference and fasting glucose were all smaller in the metformin group compared to the placebo group, indicating metformin was more effective at preventing increases in these measures over time compared to placebo.